- Home
- RNAZ vs LRHC Comparison
RNAZ vs LRHC Comparison
Compare RNAZ & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- LRHC
- Stock Information
- Founded
- RNAZ 2016
- LRHC 2004
- Country
- RNAZ United States
- LRHC United States
- Employees
- RNAZ N/A
- LRHC N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- LRHC
- Sector
- RNAZ Health Care
- LRHC
- Exchange
- RNAZ Nasdaq
- LRHC Nasdaq
- Market Cap
- RNAZ 6.1M
- LRHC 5.6M
- IPO Year
- RNAZ 2021
- LRHC 2023
- Fundamental
- Price
- RNAZ $7.97
- LRHC $0.14
- Analyst Decision
- RNAZ Strong Buy
- LRHC
- Analyst Count
- RNAZ 1
- LRHC 0
- Target Price
- RNAZ $280.00
- LRHC N/A
- AVG Volume (30 Days)
- RNAZ 32.8K
- LRHC 4.1M
- Earning Date
- RNAZ 08-13-2025
- LRHC 08-14-2025
- Dividend Yield
- RNAZ N/A
- LRHC N/A
- EPS Growth
- RNAZ N/A
- LRHC N/A
- EPS
- RNAZ N/A
- LRHC N/A
- Revenue
- RNAZ N/A
- LRHC $73,874,281.00
- Revenue This Year
- RNAZ N/A
- LRHC N/A
- Revenue Next Year
- RNAZ N/A
- LRHC N/A
- P/E Ratio
- RNAZ N/A
- LRHC N/A
- Revenue Growth
- RNAZ N/A
- LRHC 90.36
- 52 Week Low
- RNAZ $6.15
- LRHC $0.09
- 52 Week High
- RNAZ $970.20
- LRHC $2.40
- Technical
- Relative Strength Index (RSI)
- RNAZ 47.04
- LRHC 50.50
- Support Level
- RNAZ $7.32
- LRHC $0.12
- Resistance Level
- RNAZ $8.48
- LRHC $0.15
- Average True Range (ATR)
- RNAZ 0.58
- LRHC 0.01
- MACD
- RNAZ 0.41
- LRHC 0.00
- Stochastic Oscillator
- RNAZ 70.77
- LRHC 57.43
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.